Tags |
|
|
Links |
|
|
Main Subject - The First Performance Conversation
Are you so busy that you battle to find time to have the kind of conversation with people that absorbs your full attention? The kind of conversation where you're listening to them w
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ith your eyes and ears and speaking to them from your heart? Do you instead write them emails, speak in bullet points and hope that when you call their phone you'll go straight to m
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ssage bank so you can leave a concise message without getting caught up in small talk?
Are you writing your business goals and "communicating" them to everyone through email and pr
Are you writing your business goals and "communicating" them to everyone through email and pr
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
sentations? Is "consultation" when you run some brainstorming workshops so people feel that have participated (irrespective of what you do with their ideas)? Then you are very likel
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
still having trouble getting people to understand and buy-in to your strategy, performance measures and performance improvement.
Emails, brochures, PowerPoint presentations, strat
Emails, brochures, PowerPoint presentations, strat
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
gy documents and vision/mission posters fail to get people excited about organisational performance. They consist of words and maybe a few images that are usually too vague and too
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
land to paint colourful and animated visions in the minds of those that read them. These artefacts of modern organisational strategy are always political: designed more to not provo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ke those that would oppose it, designed less to evoke those that would bring it to life.
When people read things that are written in typical management-speak, what happens in their
When people read things that are written in typical management-speak, what happens in their
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
minds, honestly? They can jump to their own conclusions about what "efficient, effective and productive best practice processes" look like, or they can slide deeper into cynicism or
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
learned helplessness, or they can keep on keeping on, oblivious and unresponsive to any change in organisational direction. Not buying in, not owning it, not seeing their own aspira
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ions and values in it.
Remember: staff usually have no knowledge whatsoever of the conversations that were had before the goals were written (and polished and rewritten and polishe
Remember: staff usually have no knowledge whatsoever of the conversations that were had before the goals were written (and polished and rewritten and polishe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
some more). The seven strategic objectives or the five critical success factors are just the sanitized remains of what probably started out as a very rich, emotive and inspirationa
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
dialogue about the things that really matter right now for the organisation. And here lies the secret to getting staff to buy-in to strategy: giving them that same chance to engage
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
in rich, emotive and inspirational dialogue about what matters most right now for the organisation.
When you take the time - and it need only be one hour each month - to facilitate
When you take the time - and it need only be one hour each month - to facilitate
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
a conversation among staff about what the organisation should look, sound and feel like, then you'll have started the transformation. Stimulate this conversation with prompts like
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
hese:
* What results are implied by our goals?
* If we were already achieving our goals, what would we notice was different to how things are now?
* What are some of the things t
* What results are implied by our goals?
* If we were already achieving our goals, what would we notice was different to how things are now?
* What are some of the things t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
at our team does that directly influence how the organisation's goals are achieved?
* Are there some things our team does that impacts on other teams' performance?
* What are the
* Are there some things our team does that impacts on other teams' performance?
* What are the
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ost important results that we should be trying to produce or improve?
This is the kind of conversation that should precede any other conversation about performance with your staff
This is the kind of conversation that should precede any other conversation about performance with your staff
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
especially the individual performance management or appraisal conversations). A leader has no right to expect staff to perform in a way that improves organisational performance if t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
at leader has failed to make space and time for everyone to clearly and colourfully paint in their minds a picture of that place in the future they are collectively trying to create
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/20887/mainsubjects-The-First-Performance-Conversation.html">The First Performance Conversation</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/20887/mainsubjects-The-First-Performance-Conversation.html]The First Performance Conversation[/url]
Related Articles:
Finding Accounting Services in Your Area
Give Yourself a Vigorous Visual Audit
Bookmark it:
|